Rakuten Investment Management Inc. purchased a new stake in Danaher Corporation (NYSE:DHR – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 103,733 shares of the conglomerate’s stock, valued at approximately $19,998,000.
Several other hedge funds have also bought and sold shares of the stock. BlackRock Inc. acquired a new stake in shares of Danaher during the 2nd quarter worth approximately $10,492,520,000. Norges Bank purchased a new stake in Danaher during the fourth quarter worth $2,177,106,000. Jupiter Topco LLC purchased a new stake in Danaher during the second quarter worth $1,456,317,000. Generation Investment Management LLP acquired a new stake in Danaher during the second quarter valued at $1,287,949,000. Finally, Bank of America Corp DE purchased a new position in Danaher in the second quarter valued at $993,846,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Stock Up 0.3%
Shares of NYSE DHR opened at $216.41 on Friday. The company’s 50-day simple moving average is $199.46 and its 200-day simple moving average is $192.52. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The firm has a market cap of $152.13 billion, a price-to-earnings ratio of 38.44, a price-to-earnings-growth ratio of 2.69 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on DHR shares. Wells Fargo & Company lowered their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Piper Sandler began coverage on Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target for the company. Citigroup began coverage on Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target on the stock. Finally, TD Cowen dropped their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $228.91.
Read Our Latest Stock Report on DHR
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
